The relative benefits of finerenone vs spironolactone in CKD with T2D are unclear. Here the authors show that in >2,200 matched patients, finerenone lowers risks of cardiovascular and kidney events, death, and hyperkalemia compared with spironolactone.
- Chung-An Wang
- Hsuan-Wen Lai
- Vin-Cent Wu